Keyphrases
Induced Pluripotent Stem Cells (iPSCs)
100%
Hematopoietic Stem Cells
36%
Leukemia
26%
Acute Myeloid Leukemia
23%
Human Pluripotent Stem Cells (hPSCs)
21%
Myelodysplastic Syndrome
21%
Clonal Hematopoiesis
16%
Tet Methylcytosine Dioxygenase 2
15%
Leukemia Stem Cells
14%
Gene Therapy
14%
Myeloid Malignancies
13%
MicroRNA
12%
Genetic Modification
10%
Human Embryonic Stem Cells (hESCs)
10%
Hematopoietic Cells
10%
Stem Cell Lines
9%
Mutant Cells
9%
SRSF2
9%
Genomic Safe Harbor
8%
Cell Therapy
8%
Isogenic
8%
Macrophages
8%
Globin
8%
Human Cells
7%
Octamer-binding Transcription Factor 4 (OCT4)
7%
Clonal Evolution
7%
Stem Cell Models
7%
Escape mutation
7%
Ganciclovir Resistance
7%
Teratoma Formation
7%
Herpes Simplex Virus Thymidine Kinase Suicide Gene
7%
Runt-related Transcription Factor 1 (RUNX1)
7%
Resistance Formations
7%
CYP3A5
7%
Herpes Simplex Virus Thymidine Kinase
7%
Chromosomal Deletion
7%
Renal Transplant Recipients
7%
Tacrolimus
7%
Thalassemia
7%
SH2B3
7%
Episomal Vector
7%
Arterial Thrombosis
7%
Human iPSC
7%
Gene Transfer
7%
Enhanced Green Fluorescent Protein (eGFP)
7%
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
7%
Specific Vulnerability
7%
Genetic Parameters
7%
KDM3B
7%
Stem Cell-derived
6%
Biochemistry, Genetics and Molecular Biology
Induced Pluripotent Stem Cell
80%
Stem Cell
44%
Hematopoietic Cell
41%
Myeloid
32%
Genetics
28%
Transgene
23%
Hematopoiesis
18%
Embryonic Stem Cell
15%
Genomics
14%
Gene Therapy
13%
Reprogramming
12%
MicroRNA
11%
Clonal Evolution
11%
CRISPR
10%
Methylation
8%
Splicing Factor
8%
Teratoma
8%
Stem Cell Line
8%
Cell Mutant
8%
Globin
7%
Genotyping
7%
Genetic Divergence
7%
Gene Mutation
7%
Promoter Region
7%
Herpes Simplex Virus
7%
Thymidine Kinase
7%
SH2B3
7%
RUNX1
7%
DNA Modification
6%
Neutrophil Granulocyte
6%
Platelet
6%
Cell Engineering
6%
Genome Editing
6%
Epigenetics
5%
Gene Expression
5%
Genome Editing
5%
Macrophage
5%
Allele
5%
Stem Cell Transplantation
5%
Human Genome
5%
Progenitor Cell
5%